Rovia Clinical Research

Rovia Clinical Research

Multispecialty clinical trial site network

Overview

Rovia Clinical Research runs a network of multi-specialty clinical research sites across the United States to conduct clinical trials for drugs, devices, and diagnostics. It uses a hybrid site model that combines fully-owned, stand-alone centers with embedded specialists in independent medical practices to provide on-site trial support. This setup covers study start-up, patient enrollment, data collection and analysis, logistics, training, and business development, helping sponsors run trials more efficiently. Rovia differentiates itself through its scale, diverse patient access, and integrated services that reduce the burden on investigators, accelerated site activation, and a growing investigator network backed by acquisitions and private equity. The company’s goal is to deliver predictable, high-quality trial execution across multiple therapeutic areas by expanding its network and capabilities, serving major pharmaceutical and biotech clients with timely, well-run studies.

Significant Headcount Growth

About Rovia Clinical Research

Simplify's Rating
Why Rovia Clinical Research is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Jacksonville, Florida

Founded

2007

Get referred to Rovia Clinical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Rovia’s 2026 site count reached 18, showing continued expansion after 2025 acquisitions.
  • The company claims 1M+ EMR patients, strengthening access to underserved enrollment pools.
  • Fast study-start targets, including 45-day award-to-first-patient, appeal to CROs racing timelines.

What critics are saying

  • Rovia depends on Gauge Capital and Fidelity Direct Lending; refinancing pressure hits in 2027.
  • Private-equity rollups create integration risk, and one failed acquisition can damage enrollment quality.
  • Clinical research sites face sponsor concentration risk; a lost anchor pharma contract can cripple utilization.

What makes Rovia Clinical Research unique

  • Rovia’s 18-site, seven-state network gives sponsors faster activation than single-site competitors.
  • Direct EMR access through community physicians supports rapid feasibility and patient recruitment.
  • Gauge Capital-backed acquisition rollups in 2025 expanded specialty depth across Louisiana, Missouri, and North Carolina.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

24%

2 year growth

24%
Gauge Capital
Sep 29th, 2025
Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute

Gauge Capital, Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute, September 29 2025

Recently Posted Jobs

Sign up to get curated job recommendations

Rovia Clinical Research is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →